Monte Rosa Therapeutics Inc
NASDAQ:GLUE
Income Statement
Earnings Waterfall
Monte Rosa Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-143.3m
USD
|
Operating Income
|
-143.3m
USD
|
Other Expenses
|
8m
USD
|
Net Income
|
-135.4m
USD
|
Income Statement
Monte Rosa Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(28)
|
(35)
|
(48)
|
(61)
|
(73)
|
(86)
|
(95)
|
(103)
|
(112)
|
(122)
|
(132)
|
(141)
|
(143)
|
|
Selling, General & Administrative |
(4)
|
(6)
|
(9)
|
(13)
|
(16)
|
(20)
|
(23)
|
(30)
|
(35)
|
(40)
|
(42)
|
(38)
|
(40)
|
|
Research & Development |
(24)
|
(29)
|
(39)
|
(49)
|
(57)
|
(66)
|
(72)
|
(78)
|
(77)
|
(94)
|
(102)
|
(109)
|
(103)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
11
|
11
|
6
|
0
|
|
Operating Income |
(28)
N/A
|
(35)
-26%
|
(48)
-36%
|
(61)
-28%
|
(73)
-19%
|
(86)
-18%
|
(95)
-11%
|
(103)
-9%
|
(112)
-9%
|
(122)
-9%
|
(132)
-8%
|
(141)
-7%
|
(143)
-2%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
4
|
6
|
7
|
8
|
8
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
Total Other Income |
(8)
|
(9)
|
(9)
|
(9)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(36)
N/A
|
(44)
-22%
|
(57)
-30%
|
(70)
-23%
|
(74)
-5%
|
(86)
-16%
|
(94)
-9%
|
(101)
-8%
|
(109)
-7%
|
(117)
-7%
|
(125)
-7%
|
(133)
-6%
|
(135)
-2%
|
|
Net Income | ||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(36)
|
(44)
|
(57)
|
(70)
|
(74)
|
(86)
|
(94)
|
(101)
|
(109)
|
(117)
|
(125)
|
(133)
|
(135)
|
|
Net Income (Common) |
(36)
N/A
|
(44)
-22%
|
(57)
-30%
|
(70)
-23%
|
(74)
-5%
|
(86)
-16%
|
(94)
-9%
|
(101)
-8%
|
(109)
-7%
|
(117)
-7%
|
(125)
-7%
|
(133)
-6%
|
(135)
-2%
|
|
EPS (Diluted) |
-0.81
N/A
|
-0.99
-22%
|
-1.28
-29%
|
-1.52
-19%
|
-1.59
-5%
|
-1.85
-16%
|
-2.01
-9%
|
-2.16
-7%
|
-2.3
-6%
|
-2.36
-3%
|
-2.53
-7%
|
-2.66
-5%
|
-2.63
+1%
|